UNSPSC 51162355: Methscopolamine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162355 Methscopolamine/pseudoephedrine is a Commodity code that in practice captures state and local procurement of specialized pharmaceutical products and related healthcare supplies — though the recent opportunities on record show minimal alignment with the code's nominal scope. The Washington State Department of Corrections RFQ RFQQK13020, posted September 8, 2026 with response due October 7, 2026, solicits parenteral products, services, and equipment including total parenteral nutrition solutions, intravenous solutions, and controlled substances for correctional healthcare. The Seminole County, Florida IFB 60459723LAS, posted June 30, 2026, seeks naloxone and drug deactivation systems for community health distribution. Neither opportunity directly involves methscopolamine or pseudoephedrine compounds; the code appears to see limited relevant recent activity in state and local markets, or opportunities tagged under this code do not reflect its nominal pharmaceutical focus.

Washington State and Florida are the jurisdictions with identifiable recent activity under this code. The Washington State Department of Corrections is the primary issuing body in the visible record, seeking to supply eight correctional facilities across three regions (West, Central, and East) with an initial contract term running November 26, 2026 through June 30, 2030, with DOC retaining discretion to award up to three contractors per region and to extend the contract. DOC encourages participation from small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses under Washington State set-aside programs, and requires fixed pricing through the initial two-year term. Parenteral nutrition deliveries must meet 24-hour windows; other parenteral products require eight-hour delivery for initial supply. Contractors must carry Commercial General Liability ($1 million per occurrence / $2 million aggregate), Professional Liability ($2 million per occurrence / aggregate), Business Automobile Liability ($1 million per occurrence / $2 million aggregate), and Cyber Liability ($2 million per occurrence / aggregate) coverage, naming the State of Washington as additional insured.